<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36012603</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>16</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Oxidative Stress in Amyotrophic Lateral Sclerosis: Synergy of Genetic and Environmental Factors.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9339</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23169339</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a grievous neurodegenerative disease whose survival is limited to only a few years. In spite of intensive research to discover the underlying mechanisms, the results are fairly inconclusive. Multiple hypotheses have been regarded, including genetic, molecular, and cellular processes. Notably, oxidative stress has been demonstrated to play a crucial role in ALS pathogenesis. In addition to already recognized and exhaustively studied genetic mutations involved in oxidative stress production, exposure to various environmental factors (e.g., electromagnetic fields, solvents, pesticides, heavy metals) has been suggested to enhance oxidative damage. This review aims to describe the main processes influenced by the most frequent genetic mutations and environmental factors concurring in oxidative stress occurrence in ALS and the potential therapeutic molecules capable of diminishing the ALS related pro-oxidative status.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Motataianu</LastName><ForeName>Anca</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540136 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1st Neurology Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serban</LastName><ForeName>Georgiana</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8078-2177</Identifier><AffiliationInfo><Affiliation>Doctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcutean</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540136 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1st Neurology Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balasa</LastName><ForeName>Rodica</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540136 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1st Neurology Clinic, Emergency Clinical County Hospital Targu Mures, 540136 Targu Mures, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral School, "George Emil Palade" University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Targu Mures, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PN-III-P1-1.1-TE-2021-0960</GrantID><Agency>Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010575">Pesticides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004574" MajorTopicYN="N">Electromagnetic Fields</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010575" MajorTopicYN="Y">Pesticides</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">environmental factors</Keyword><Keyword MajorTopicYN="N">genetic factors</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36012603</ArticleId><ArticleId IdType="pmc">PMC9409178</ArticleId><ArticleId IdType="doi">10.3390/ijms23169339</ArticleId><ArticleId IdType="pii">ijms23169339</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;710:132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., Roos P.M., Piehl F., Kamel F., Fang F. Risk factors for amyotrophic lateral sclerosis. Clin. Epidemiol. 2015;7:181&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco V., Longone P., Spalloni A., Pieroni L., Urbani A. Crosstalk Between Oxidative Stress and Mitochondrial Damage: Focus on Amyotrophic Lateral Sclerosis. Adv. Exp. Med. Biol. 2019;1158:71&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">31452136</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chio A., de Carvalho M., Ince P.G., Lin C., Miller R.G., Mitsumoto H., et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12:310&#x2013;322. doi: 10.1016/S1474-4422(13)70036-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko K., Ciesla L. Amyotrophic lateral sclerosis. Prog. Med. Chem. 2019;58:63&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">30879475</ArticleId></ArticleIdList></Reference><Reference><Citation>Sbodio J.I., Snyder S.H., Paul B.D. Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities. Antioxid. Redox. Signal. 2019;30:1450&#x2013;1499. doi: 10.1089/ars.2017.7321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7321</ArticleId><ArticleId IdType="pmc">PMC6393771</ArticleId><ArticleId IdType="pubmed">29634350</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne B.A., Chinnery P.F. Mitochondrial dysfunction in aging: Much progress but many unresolved questions. Biochim. Biophys. Acta. 2015;1847:1347&#x2013;1353. doi: 10.1016/j.bbabio.2015.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2015.05.022</ArticleId><ArticleId IdType="pmc">PMC4580208</ArticleId><ArticleId IdType="pubmed">26050973</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha-Oliveira T., Montezinho L., Mendes C., Firuzi O., Saso L., Oliveira P.J., Silva F.S.G. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxid. Med. Cell Longev. 2020;15:5021694. doi: 10.1155/2020/5021694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5021694</ArticleId><ArticleId IdType="pmc">PMC7683149</ArticleId><ArticleId IdType="pubmed">33274002</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzino G., Irrera N., Cucinotta M., Pallio G., Mannino F., Arcoraci V., Squadrito F., Altavilla D., Bitto A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell Longev. 2017;2017:8416763. doi: 10.1155/2017/8416763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/8416763</ArticleId><ArticleId IdType="pmc">PMC5551541</ArticleId><ArticleId IdType="pubmed">28819546</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M.T., Valle C., Bozzo F., Cozzolino M. Oxidative stress and mitochondrial damage: Importance in non-SOD1 ALS. Front. Cell Neurosci. 2015;9:41. doi: 10.3389/fncel.2015.00041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00041</ArticleId><ArticleId IdType="pmc">PMC4330888</ArticleId><ArticleId IdType="pubmed">25741238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kausar S., Wang F., Cui H. The Role of Mitochondria in Reactive Oxygen Species Generation and Its Implications for Neurodegenerative Diseases. Cells. 2018;7:274. doi: 10.3390/cells7120274.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells7120274</ArticleId><ArticleId IdType="pmc">PMC6316843</ArticleId><ArticleId IdType="pubmed">30563029</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009;417:1&#x2013;13. doi: 10.1042/BJ20081386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20081386</ArticleId><ArticleId IdType="pmc">PMC2605959</ArticleId><ArticleId IdType="pubmed">19061483</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand M.D. The sites and topology of mitochondrial superoxide production. Exp. Gerontol. 2010;45:466&#x2013;472. doi: 10.1016/j.exger.2010.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2010.01.003</ArticleId><ArticleId IdType="pmc">PMC2879443</ArticleId><ArticleId IdType="pubmed">20064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui H., Kong Y., Zhang H. Oxidative stress, mitochondrial dysfunction, and aging. J. Signal. Transduct. 2012;2012:646354. doi: 10.1155/2012/646354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/646354</ArticleId><ArticleId IdType="pmc">PMC3184498</ArticleId><ArticleId IdType="pubmed">21977319</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedzielska E., Smaga I., Gawlik M., Moniczewski A., Stankowicz P., Pera J., Filip M. Oxidative Stress in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:4094&#x2013;4125. doi: 10.1007/s12035-015-9337-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9337-5</ArticleId><ArticleId IdType="pmc">PMC4937091</ArticleId><ArticleId IdType="pubmed">26198567</ArticleId></ArticleIdList></Reference><Reference><Citation>Agar J., Durham H. Relevance of oxidative injury in the pathogenesis of motor neuron diseases. Amyotroph. Lateral. Scler. Other Motor. Neuron. Disord. 2003;4:232&#x2013;242. doi: 10.1080/14660820310011278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820310011278</ArticleId><ArticleId IdType="pubmed">14753657</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Kukreti R., Saso L., Kukreti S. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules. 2019;24:1583. doi: 10.3390/molecules24081583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24081583</ArticleId><ArticleId IdType="pmc">PMC6514564</ArticleId><ArticleId IdType="pubmed">31013638</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Velde C., McDonald K.K., Boukhedimi Y., McAlonis-Downes M., Lobsiger C.S., Bel Hadj S., Zandona A., Julien J.P., Shah S.B., Cleveland D.W. Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS ONE. 2011;6:e22031. doi: 10.1371/journal.pone.0022031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0022031</ArticleId><ArticleId IdType="pmc">PMC3136936</ArticleId><ArticleId IdType="pubmed">21779368</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft A.D., Resch J.M., Johnson D.A., Johnson J.A. Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Exp. Neurol. 2007;207:107&#x2013;117. doi: 10.1016/j.expneurol.2007.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2007.05.026</ArticleId><ArticleId IdType="pmc">PMC2062571</ArticleId><ArticleId IdType="pubmed">17631292</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu G.N., Kumar A., Chandra R., Puri S.K., Singh R.L., Kalita J., Misra U.K. Oxidant-antioxidant imbalance in the erythrocytes of sporadic amyotrophic lateral sclerosis patients correlates with the progression of disease. Neurochem. Int. 2008;52:1284&#x2013;1289. doi: 10.1016/j.neuint.2008.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2008.01.009</ArticleId><ArticleId IdType="pubmed">18308427</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico E., Factor-Litvak P., Santella R.M., Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free. Radic. Biol. Med. 2013;65:509&#x2013;527. doi: 10.1016/j.freeradbiomed.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson C.J., Bredvik K., Burstein S.R., Davis C., Meadows S.M., Dash J., Case L., Milner T.A., Kawamata H., Zuberi A., et al. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response. Acta Neuropathol. 2019;138:103&#x2013;121. doi: 10.1007/s00401-019-01989-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01989-y</ArticleId><ArticleId IdType="pmc">PMC6571048</ArticleId><ArticleId IdType="pubmed">30877432</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S., Ait-El-Mkadem S., Chaussenot A., Genin E.C., Lacas-Gervais S., Fragaki K., Berg-Alonso L., Kageyama Y., Serre V., Moore D.G., et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137 Pt. 8:2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin E.C., Plutino M., Bannwarth S., Villa E., Cisneros-Barroso E., Roy M., Ortega-Vila B., Fragaki K., Lespinasse F., Pinero-Martos E., et al. CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol. Med. 2016;8:58&#x2013;72. doi: 10.15252/emmm.201505496.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201505496</ArticleId><ArticleId IdType="pmc">PMC4718158</ArticleId><ArticleId IdType="pubmed">26666268</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehvil&#xe4;inen P., Koistinaho J., Gundars G. Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis. Front. Cell Neurosci. 2014;8:126. doi: 10.3389/fncel.2014.00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00126</ArticleId><ArticleId IdType="pmc">PMC4023018</ArticleId><ArticleId IdType="pubmed">24847211</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H., Manfredi G. Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria. Hum. Mol. Genet. 2008;17:3303&#x2013;3317. doi: 10.1093/hmg/ddn226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn226</ArticleId><ArticleId IdType="pmc">PMC2566526</ArticleId><ArticleId IdType="pubmed">18703498</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafuri F., Ronchi D., Magri F., Comi G.P., Corti S. SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis. Front. Cell Neurosci. 2015;9:336. doi: 10.3389/fncel.2015.00336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00336</ArticleId><ArticleId IdType="pmc">PMC4548205</ArticleId><ArticleId IdType="pubmed">26379505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Warita H., Murakami T., Shibata N., Komori T., Abe K., Kobayashi M., Iwata M. Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 2005;109:247&#x2013;255. doi: 10.1007/s00401-004-0939-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0939-7</ArticleId><ArticleId IdType="pubmed">15614580</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins C.M., Jung C., Ding H., Xu Z. Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J. Neurosci. 2002;22:RC215. doi: 10.1523/JNEUROSCI.22-06-j0001.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-06-j0001.2002</ArticleId><ArticleId IdType="pmc">PMC6758252</ArticleId><ArticleId IdType="pubmed">11886899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitchler M.J., Domann F.E. Regulation of CuZnSOD and its redox signaling potential: Implications for amyotrophic lateral sclerosis. Antioxid. Redox. Signal. 2014;20:1590&#x2013;1598. doi: 10.1089/ars.2013.5385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5385</ArticleId><ArticleId IdType="pmc">PMC3960847</ArticleId><ArticleId IdType="pubmed">23795822</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Mead R.J., Shaw P.J. Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta. 2006;1762:1051&#x2013;1067. doi: 10.1016/j.bbadis.2006.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.008</ArticleId><ArticleId IdType="pubmed">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll M.C., Outten C.E., Proescher J.B., Rosenfeld L., Watson W.H., Whitson L.J., Hart P.J., Jensen L.T., Cizewski Culotta V. The effects of glutaredoxin and copper activation pathways on the disulfide and stability of Cu,Zn superoxide dismutase. J. Biol. Chem. 2006;281:28648&#x2013;28656. doi: 10.1074/jbc.M600138200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M600138200</ArticleId><ArticleId IdType="pmc">PMC2757158</ArticleId><ArticleId IdType="pubmed">16880213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., Brown R.H., Jr. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E., Gordon D., Thompson A.G., Finelli M.J., Dafinca R., Candalija A., Charles P.D., M&#xe4;ger I., Wood M.J., Fischer R., et al. An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress. Neurobiol. Dis. 2020;144:105050. doi: 10.1016/j.nbd.2020.105050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105050</ArticleId><ArticleId IdType="pubmed">32800996</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.M., Ernst P., Foglieni C., Jambeau M., Gilhespy L.A.B., Laferriere F., Maniecka Z., Pl&#xfc;ckthun A., Mittl P., et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 2017;8:45. doi: 10.1038/s41467-017-00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A., Vande Velde C. Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS? Front. Cell Neurosci. 2015;9:423. doi: 10.3389/fncel.2015.00423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A.M., Koppers M., Groen E.J.N., van den Heuvel D.M.A., Dini Modigliani S., Anink J.J., Fumoto K., van Diggelen F., Snelting A., Sodaar P., et al. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta. Neuropathol. 2016;132:175&#x2013;196. doi: 10.1007/s00401-016-1575-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1575-8</ArticleId><ArticleId IdType="pmc">PMC4947123</ArticleId><ArticleId IdType="pubmed">27164932</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. Functional Significance of TDP-43 Mutations in Disease. Adv. Genet. 2015;91:1&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">26410029</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.K., Park S., Liebman S.W. Respiration Enhances TDP-43 Toxicity, but TDP-43 Retains Some Toxicity in the Absence of Respiration. J. Mol. Biol. 2019;431:2050&#x2013;2059. doi: 10.1016/j.jmb.2019.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.03.014</ArticleId><ArticleId IdType="pmc">PMC6502655</ArticleId><ArticleId IdType="pubmed">30905713</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., Jara J.H., Kocak N., Rylaarsdam L.E., Kim K.D., Bigio E.H., Hande &#xd6;zdinler P. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta. Neuropathol. 2019;137:47&#x2013;69. doi: 10.1007/s00401-018-1934-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1934-8</ArticleId><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Hwang A.W., Unger T., Trojanowski J.Q., Lee V.M. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J. 2012;31:1241&#x2013;1252. doi: 10.1038/emboj.2011.471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.471</ArticleId><ArticleId IdType="pmc">PMC3297986</ArticleId><ArticleId IdType="pubmed">22193716</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Hwang A.W., Restrepo C.R., Yuan C.X., Trojanowski J.Q., Lee V.M. An acetylation switch controls TDP-43 function and aggregation propensity. Nat. Commun. 2015;6:5845. doi: 10.1038/ncomms6845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6845</ArticleId><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J., Cortez C., Gan W.B., Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W., Li X., Shi J., Guo Y., Li Z., Li C. Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell. Neuroscience. 2010;169:1621&#x2013;1629. doi: 10.1016/j.neuroscience.2010.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.06.018</ArticleId><ArticleId IdType="pubmed">20600671</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y.P., Che F.Y., Su Q.P., Lu Y.C., You C.P., Huang L.M., Wang S.G., Wang L., Yu J.X. Effects of mutant TDP-43 on the Nrf2/ARE pathway and protein expression of MafK and JDP2 in NSC-34 cells. Genet. Mol. Res. 2017;16:gmr16029638. doi: 10.4238/gmr16029638.</Citation><ArticleIdList><ArticleId IdType="doi">10.4238/gmr16029638</ArticleId><ArticleId IdType="pubmed">28510254</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y., Huang E.J. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res. 2016;1647:65&#x2013;78. doi: 10.1016/j.brainres.2016.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.03.036</ArticleId><ArticleId IdType="pmc">PMC5003642</ArticleId><ArticleId IdType="pubmed">27033831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Rouleau G.A., Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: Summary and update. Hum. Mutat. 2013;34:812&#x2013;826. doi: 10.1002/humu.22319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22319</ArticleId><ArticleId IdType="pubmed">23559573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Guo W., Mitra J., Hegde P.M., Vandoorne T., Eckelmann B.J., Mitra S., Tomkinson A.E., Van Den Bosch L., Hegde M.L. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nat. Commun. 2018;9:3683. doi: 10.1038/s41467-018-06111-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06111-6</ArticleId><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.D., Ichida J.K. C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;713:134523. doi: 10.1016/j.neulet.2019.134523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2019.134523</ArticleId><ArticleId IdType="pubmed">31568865</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Arzberger T., Gr&#xe4;sser F.A., Gijselinck I., May S., Rentzsch K., Weng S.M., Schludi M.H., van der Zee J., Cruts M., et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126:881&#x2013;893. doi: 10.1007/s00401-013-1189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai S.C., Nana A.L., Yokoyama J.S., Seeley W.W. C9orf72-FTD/ALS pathogenesis: Evidence from human neuropathological studies. Acta Neuropathol. 2019;137:1&#x2013;26. doi: 10.1007/s00401-018-1921-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1921-0</ArticleId><ArticleId IdType="pmc">PMC6546170</ArticleId><ArticleId IdType="pubmed">30368547</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E., Colombrita C., Gumina V., Borghi M.O., Dusi S., Doretti A., Fagiolari G., Invernizzi F., Moggio M., Tiranti V., et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol. Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., Gao F.B. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A., Ben-Dor I., Ottolenghi M., Turetsky T., Gil Y., Sweetat S., Perez L., Belzer V., Casden N., Steiner D., et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;289. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Emara M.M., Ivanov P., Hickman T., Dawra N., Tisdale S., Kedersha N., Hu G.F., Anderson P. Angiogenin-induced tRNA-derived stress-induced RNAs promote stress-induced stress granule assembly. J. Biol. Chem. 2010;285:10959&#x2013;10968. doi: 10.1074/jbc.M109.077560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.077560</ArticleId><ArticleId IdType="pmc">PMC2856301</ArticleId><ArticleId IdType="pubmed">20129916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang T.T., Johnson D.A., Raines R.T., Johnson J.A. Angiogenin activates the astrocytic Nrf2/antioxidant-response element pathway and thereby protects murine neurons from oxidative stress. J. Biol. Chem. 2019;294:15095&#x2013;15103. doi: 10.1074/jbc.RA119.008491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.008491</ArticleId><ArticleId IdType="pmc">PMC6791309</ArticleId><ArticleId IdType="pubmed">31431502</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang T.T., Smith T.P., Raines R.T. A Boronic Acid Conjugate of Angiogenin that Shows ROS-Responsive Neuroprotective Activity. Angew. Chem. Int. Ed. Engl. 2017;56:2619&#x2013;2622. doi: 10.1002/anie.201611446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201611446</ArticleId><ArticleId IdType="pmc">PMC5418131</ArticleId><ArticleId IdType="pubmed">28120377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N., LeClerc A.L., Keagle P.J., Glass J.D., Wills A.M., van Blitterswijk M., Bosco D.A., Rodriguez-Leyva I., Gellera C., Ratti A., et al. Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann. Neurol. 2010;68:102&#x2013;107. doi: 10.1002/ana.21993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21993</ArticleId><ArticleId IdType="pmc">PMC2945725</ArticleId><ArticleId IdType="pubmed">20582942</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills A.M., Cronin S., Slowik A., Kasperaviciute D., Van Es M.A., Morahan J.M., Valdmanis P.N., Meininger V., Melki J., Shaw C.E., et al. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology. 2009;73:16&#x2013;24. doi: 10.1212/WNL.0b013e3181a18674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a18674</ArticleId><ArticleId IdType="pmc">PMC2707108</ArticleId><ArticleId IdType="pubmed">19321847</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Blitterswijk M., Blokhuis A., van Es M.A., van Vught P.W., Rowicka P.A., Schelhaas H.J., van der Kooi A.J., de Visser M., Veldink J.H., van den Berg L.H. Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients. Neurobiol. Aging. 2012;33:1845.e1. doi: 10.1016/j.neurobiolaging.2012.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.01.007</ArticleId><ArticleId IdType="pubmed">22330174</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna J., Leleu J.P., Preux P.M., Corcia P., Couratier P., Marin B., Boumediene F., Fralim Consortium Residential exposure to ultra high frequency electromagnetic fields emitted by Global System for Mobile (GSM) antennas and amyotrophic lateral sclerosis incidence: A geo-epidemiological population-based study. Environ. Res. 2019;176:108525. doi: 10.1016/j.envres.2019.108525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2019.108525</ArticleId><ArticleId IdType="pubmed">31226626</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunnarsson L.G., Bodin L. Amyotrophic Lateral Sclerosis and Occupational Exposures: A Systematic Literature Review and Meta-Analyses. Int. J. Environ. Res. Public. Health. 2018;15:2371. doi: 10.3390/ijerph15112371.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph15112371</ArticleId><ArticleId IdType="pmc">PMC6265680</ArticleId><ArticleId IdType="pubmed">30373166</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunnarsson L.G., Bodin L. Occupational Exposures and Neurodegenerative Diseases-A Systematic Literature Review and Meta-Analyses. Int. J. Environ. Res. Public. Health. 2019;16:337. doi: 10.3390/ijerph16030337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph16030337</ArticleId><ArticleId IdType="pmc">PMC6388365</ArticleId><ArticleId IdType="pubmed">30691095</ArticleId></ArticleIdList></Reference><Reference><Citation>Koeman T., Slottje P., Schouten L.J., Peters S., Huss A., Veldink J.H., Kromhout H., van den Brandt P.A., Vermeulen R. Occupational exposure and amyotrophic lateral sclerosis in a prospective cohort. Occup. Environ. Med. 2017;74:578&#x2013;585. doi: 10.1136/oemed-2016-103780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oemed-2016-103780</ArticleId><ArticleId IdType="pubmed">28356332</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini T., Tesauro M., Fiore M., Malagoli C., Consonni M., Violi F., Iacuzio L., Arcolin E., Oliveri Conti G., Cristaldi A., et al. Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study. Int. J. Environ. Res. Public. Health. 2020;17:2882. doi: 10.3390/ijerph17082882.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17082882</ArticleId><ArticleId IdType="pmc">PMC7216189</ArticleId><ArticleId IdType="pubmed">32331298</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelen M., Vermeulen R.C., van Dillen L.S., van der Kooi A.J., Huss A., de Visser M., van den Berg L.H., Veldink J.H. Residential exposure to extremely low frequency electromagnetic fields and the risk of ALS. Neurology. 2014;83:1767&#x2013;1769. doi: 10.1212/WNL.0000000000000952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000952</ArticleId><ArticleId IdType="pubmed">25274850</ArticleId></ArticleIdList></Reference><Reference><Citation>Riancho J., Sanchez de la Torre J.R., Paz-Fajardo L., Limia C., Santurtun A., Cifra M., Kourtidis K., Fdez-Arroyabe P. The role of magnetic fields in neurodegenerative diseases. Int. J. Biometeorol. 2021;65:107&#x2013;117. doi: 10.1007/s00484-020-01896-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00484-020-01896-y</ArticleId><ArticleId IdType="pubmed">32198562</ArticleId></ArticleIdList></Reference><Reference><Citation>Capozzella A., Sacco C., Chighine A., Loreti B., Scala B., Casale T., Sinibaldi F., Tomei G., Giubilati R., Tomei F., et al. Work related etiology of amyotrophic lateral sclerosis (ALS): A meta-analysis. Ann. Ig. 2014;26:456&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">25405377</ArticleId></ArticleIdList></Reference><Reference><Citation>Consales C., Merla C., Marino C., Benassi B. Electromagnetic fields, oxidative stress, and neurodegeneration. Int. J. Cell Biol. 2012;2012:683897. doi: 10.1155/2012/683897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/683897</ArticleId><ArticleId IdType="pmc">PMC3444040</ArticleId><ArticleId IdType="pubmed">22991514</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulletier de Gannes F., Ruffi&#xe9; G., Taxile M., Ladev&#xe8;ze E., Hurtier A., Haro E., Duleu S., Charlet de Sauvage R., Billaudel B., Geffard M., et al. Amyotrophic lateral sclerosis (ALS) and extremely-low frequency (ELF) magnetic fields: A study in the SOD-1 transgenic mouse model. Amyotroph. Lateral. Scler. 2009;10:370&#x2013;373. doi: 10.3109/17482960802320396.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802320396</ArticleId><ArticleId IdType="pubmed">19922126</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini T., Hatch E.E., Vinceti M. Residential exposure to electromagnetic fields and risk of amyotrophic lateral sclerosis: A dose-response meta-analysis. Sci. Rep. 2021;11:11939. doi: 10.1038/s41598-021-91349-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91349-2</ArticleId><ArticleId IdType="pmc">PMC8185090</ArticleId><ArticleId IdType="pubmed">34099747</ArticleId></ArticleIdList></Reference><Reference><Citation>Falone S., Mirabilio A., Carbone M.C., Zimmitti V., Di Loreto S., Mariggi&#xf2; M.A., Mancinelli R., Di Ilio C., Amicarelli F. Chronic exposure to 50 Hz magnetic fields causes a significant weakening of antioxidant defence systems in aged rat brain. Int. J. Biochem. Cell Biol. 2008;40:2762&#x2013;2770. doi: 10.1016/j.biocel.2008.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2008.05.022</ArticleId><ArticleId IdType="pubmed">18585472</ArticleId></ArticleIdList></Reference><Reference><Citation>Jelenkovi&#x107; A., Jana&#x107; B., Pesi&#x107; V., Jovanovi&#x107; D.M., Vasiljevi&#x107; I., Proli&#x107; Z. Effects of extremely low-frequency magnetic field in the brain of rats. Brain. Res. Bull. 2006;68:355&#x2013;360. doi: 10.1016/j.brainresbull.2005.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2005.09.011</ArticleId><ArticleId IdType="pubmed">16377443</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshiro S., Morioka M.S., Kikuchi M. Dysregulation of iron metabolism in Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and amyotrophic lateral sclerosis. Adv. Pharmacol. Sci. 2011;2011:378278. doi: 10.1155/2011/378278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/378278</ArticleId><ArticleId IdType="pmc">PMC3195304</ArticleId><ArticleId IdType="pubmed">22013437</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebl M.P., Windschmitt J., Besemer A.S., Sch&#xe4;fer A.K., Reber H., Behl C., Clement A.M. Low-frequency magnetic fields do not aggravate disease in mouse models of Alzheimer&#x2019;s disease and amyotrophic lateral sclerosis. Sci. Rep. 2015;5:8585. doi: 10.1038/srep08585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep08585</ArticleId><ArticleId IdType="pmc">PMC4341214</ArticleId><ArticleId IdType="pubmed">25717019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratner M.H., Jabre J.F., Ewing W.M., Abou-Donia M., Oliver L.C. Amyotrophic lateral sclerosis&#x2014;A case report and mechanistic review of the association with toluene and other volatile organic compounds. Am. J. Ind. Med. 2018;61:251&#x2013;260. doi: 10.1002/ajim.22791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajim.22791</ArticleId><ArticleId IdType="pubmed">29125194</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson A.S., Hansen J., Thompson S., Gredal O., Weisskopf M.G. A mixtures approach to solvent exposures and amyotrophic lateral sclerosis: A population-based study in Denmark. Eur. J. Epidemiol. 2020;35:241&#x2013;249. doi: 10.1007/s10654-020-00624-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00624-5</ArticleId><ArticleId IdType="pmc">PMC7176306</ArticleId><ArticleId IdType="pubmed">32193761</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters T.L., Kamel F., Lundholm C., Feychting M., Weibull C.E., Sandler D.P., Wiebert P., Spar&#xe9;n P., Ye W., Fang F. Occupational exposures and the risk of amyotrophic lateral sclerosis. Occup. Environ. Med. 2017;74:87&#x2013;92. doi: 10.1136/oemed-2016-103700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oemed-2016-103700</ArticleId><ArticleId IdType="pmc">PMC5451107</ArticleId><ArticleId IdType="pubmed">27418175</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., Quinlan P., Ye W., Barber M.K., Umbach D.M., Sandler D.P., Kamel F. Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ. Health. Perspect. 2009;117:1387&#x2013;1392. doi: 10.1289/ehp.0900580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.0900580</ArticleId><ArticleId IdType="pmc">PMC2737014</ArticleId><ArticleId IdType="pubmed">19750102</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A.L., Johnson N.J., Cudkowicz M.E., Eum K.D., Weisskopf M.G. Job-related formaldehyde exposure and ALS mortality in the USA. J. Neurol. Neurosurg. Psychiatry. 2016;87:786&#x2013;788. doi: 10.1136/jnnp-2015-310750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310750</ArticleId><ArticleId IdType="pmc">PMC4738165</ArticleId><ArticleId IdType="pubmed">26169306</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf M.G., Morozova N., O&#x2019;Reilly E.J., McCullough M.L., Calle E.E., Thun M.J., Ascherio A. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2009;80:558&#x2013;561. doi: 10.1136/jnnp.2008.156976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.156976</ArticleId><ArticleId IdType="pmc">PMC2765376</ArticleId><ArticleId IdType="pubmed">19372290</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek A.M., Barchowsky A., Bowser R., Youk A., Talbott E.O. Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: A meta-analysis of epidemiological studies: Pesticide exposure as a risk factor for ALS. Environ. Res. 2012;117:112&#x2013;119. doi: 10.1016/j.envres.2012.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2012.06.007</ArticleId><ArticleId IdType="pubmed">22819005</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew A.S., Caller T.A., Tandan R., Duell E.J., Henegan P.L., Field N.C., Bradley W.G., Stommel E.W. Environmental and Occupational Exposures and Amyotrophic Lateral Sclerosis in New England. Neurodegener. Dis. 2017;17:110&#x2013;116. doi: 10.1159/000453359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000453359</ArticleId><ArticleId IdType="pmc">PMC5383428</ArticleId><ArticleId IdType="pubmed">28122372</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek A.M., Barchowsky A., Bowser R., Heiman-Patterson T., Lacomis D., Rana S., Youk A., Talbott E.O. Exposure to hazardous air pollutants and the risk of amyotrophic lateral sclerosis. Environ. Pollut. 2015;197:181&#x2013;186. doi: 10.1016/j.envpol.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envpol.2014.12.010</ArticleId><ArticleId IdType="pubmed">25544309</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva T., Michailova A., Panev T., Popov T. Possibilities to control the health risk of petrochemical workers. Int. Arch. Occup. Environ. Health. 2002;75:S21&#x2013;S26. doi: 10.1007/s00420-002-0344-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00420-002-0344-2</ArticleId><ArticleId IdType="pubmed">12397407</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong I., Marja&#x144;ska M., Deelchand D.K., Eberly L.E., Walk D., &#xd6;z G. Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis. Neurochem. Res. 2017;42:1833&#x2013;1844. doi: 10.1007/s11064-017-2248-2. Erratum in 2017, 42, 1845&#x2013;1846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2248-2</ArticleId><ArticleId IdType="pmc">PMC5488866</ArticleId><ArticleId IdType="pubmed">28367604</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster B.R., Pomper M.G., Callaghan B.C., Petrou M., Edden R.A., Mohamed M.A., Welsh R.C., Carlos R.C., Barker P.B., Feldman E.L. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA. Neurol. 2013;70:1009&#x2013;1016. doi: 10.1001/jamaneurol.2013.234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.234</ArticleId><ArticleId IdType="pmc">PMC4382938</ArticleId><ArticleId IdType="pubmed">23797905</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiduschat N., Mao X., Hupf J., Armstrong N., Kang G., Lange D.J., Mitsumoto H., Shungu D.C. Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique. Neurosci. Lett. 2014;570:102&#x2013;107. doi: 10.1016/j.neulet.2014.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2014.04.020</ArticleId><ArticleId IdType="pubmed">24769125</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhre O., Fonnum F. The effect of aliphatic, naphthenic, and aromatic hydrocarbons on production of reactive oxygen species and reactive nitrogen species in rat brain synaptosome fraction: The involvement of calcium, nitric oxide synthase, mitochondria, and phospholipase A. Biochem. Pharmacol. 2001;62:119&#x2013;128. doi: 10.1016/S0006-2952(01)00652-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-2952(01)00652-9</ArticleId><ArticleId IdType="pubmed">11377403</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills K.R., Nithi K.A. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis. Muscle Nerve. 1997;20:1137&#x2013;1141. doi: 10.1002/(SICI)1097-4598(199709)20:9&lt;1137::AID-MUS7&gt;3.0.CO;2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199709)20:9&lt;1137::AID-MUS7&gt;3.0.CO;2-9</ArticleId><ArticleId IdType="pubmed">9270669</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi H., Doh-ura K., Kawashima T., Kira J., Iwaki T. Immunohistochemical analysis of spinal cord lesions in amyotrophic lateral sclerosis using microtubule-associated protein 2 (MAP2) antibodies. Acta Neuropathol. 1999;97:13&#x2013;21. doi: 10.1007/s004010050950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050950</ArticleId><ArticleId IdType="pubmed">9930890</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah C.A., Nguyen M.D., Julien J.P., Leclerc N. Altered levels and distribution of microtubule-associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 2003;84:77&#x2013;86. doi: 10.1046/j.1471-4159.2003.01505.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01505.x</ArticleId><ArticleId IdType="pubmed">12485403</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotohda T., Tokunaga I., Kitamura O., Kubo S. Toluene inhalation induced neuronal damage in the spinal cord and changes of neurotrophic factors in rat. Leg. Med. 2007;9:123&#x2013;127. doi: 10.1016/j.legalmed.2006.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.legalmed.2006.11.014</ArticleId><ArticleId IdType="pubmed">17197224</ArticleId></ArticleIdList></Reference><Reference><Citation>Oggiano R., Solinas G., Forte G., Bocca B., Farace C., Pisano A., Sotgiu M.A., Clemente S., Malaguarnera M., Fois A.G., et al. Trace elements in ALS patients and their relationships with clinical severity. Chemosphere. 2018;197:457&#x2013;466. doi: 10.1016/j.chemosphere.2018.01.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemosphere.2018.01.076</ArticleId><ArticleId IdType="pubmed">29366958</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S., Broberg K., Gallo V., Levi M., Kippler M., Vineis P., Veldink J., van den Berg L., Middleton L., Travis R.C., et al. Blood Metal Levels and Amyotrophic Lateral Sclerosis Risk: A Prospective Cohort. Ann. Neurol. 2021;89:125&#x2013;133. doi: 10.1002/ana.25932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25932</ArticleId><ArticleId IdType="pmc">PMC7756568</ArticleId><ArticleId IdType="pubmed">33068316</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin Kullmann J.A., Pamphlett R. A Comparison of Mercury Exposure from Seafood Consumption and Dental Amalgam Fillings in People with and without Amyotrophic Lateral Sclerosis (ALS): An International Online Case-Control Study. Int. J. Environ. Res. Public Health. 2018;15:2874. doi: 10.3390/ijerph15122874.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph15122874</ArticleId><ArticleId IdType="pmc">PMC6313312</ArticleId><ArticleId IdType="pubmed">30558238</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew A.S., O&#x2019;Brien K.M., Jackson B.P., Sandler D.P., Kaye W.E., Wagner L., Stommel E.W., Horton D.K., Mehta P., Weinberg C.R. Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. study. Amyotroph. Lateral. Scler. Frontotemporal. Degener. 2020;21:420&#x2013;427. doi: 10.1080/21678421.2020.1753777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1753777</ArticleId><ArticleId IdType="pmc">PMC7483924</ArticleId><ArticleId IdType="pubmed">32329357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mano Y., Takayanagi T., Ishitani A., Hirota T. Mercury in hair of patients with ALS. Rinsho Shinkeigaku. 1989;29:844&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">2805505</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocca B., Forte G., Oggiano R., Clemente S., Asara Y., Peruzzu A., Farace C., Pala S., Fois A.G., Pirina P., et al. Level of neurotoxic metals in amyotrophic lateral sclerosis: A population-based case-control study. J. Neurol. Sci. 2015;359:11&#x2013;17. doi: 10.1016/j.jns.2015.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.10.023</ArticleId><ArticleId IdType="pubmed">26671079</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriwaka F., Satoh H., Ejima A., Watanabe C., Tashiro K., Hamada T., Matsumoto A., Shima K., Yanagihara T., Fukazawa T. Mercury and selenium contents in amyotrophic lateral sclerosis in Hokkaido, the northernmost island of Japan. J. Neurol. Sci. 1993;118:38&#x2013;42. doi: 10.1016/0022-510X(93)90243-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(93)90243-R</ArticleId><ArticleId IdType="pubmed">8229049</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson A.S., Hansen J., Gredal O., Weisskopf M.G. Study of Occupational Chromium, Iron, and Nickel Exposure and Amyotrophic Lateral Sclerosis in Denmark. Int. J. Environ. Res. Public Health. 2020;17:8086. doi: 10.3390/ijerph17218086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17218086</ArticleId><ArticleId IdType="pmc">PMC7663552</ArticleId><ArticleId IdType="pubmed">33147887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M.D., Little J., Gomes J., Cashman N.R., Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. 2017;61:101&#x2013;130. doi: 10.1016/j.neuro.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.06.015</ArticleId><ArticleId IdType="pubmed">27377857</ArticleId></ArticleIdList></Reference><Reference><Citation>Farace C., Fenu G., Lintas S., Oggiano R., Pisano A., Sabalic A., Solinas G., Bocca B., Forte G., Madeddu R. Amyotrophic lateral sclerosis and lead: A systematic update. Neurotoxicology. 2020;81:80&#x2013;88. doi: 10.1016/j.neuro.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2020.09.003</ArticleId><ArticleId IdType="pubmed">32941938</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Filippini T., Mandrioli J., Violi F., Bargellini A., Weuve J., Fini N., Grill P., Michalke B. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study. J. Trace. Elem. Med. Biol. 2017;43:121&#x2013;125. doi: 10.1016/j.jtemb.2016.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2016.12.012</ArticleId><ArticleId IdType="pmc">PMC5495626</ArticleId><ArticleId IdType="pubmed">28089071</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F., Umbach D.M., Stallone L., Richards M., Hu H., Sandler D.P. Association of lead exposure with survival in amyotrophic lateral sclerosis. Environ. Health Perspect. 2008;116:943&#x2013;947. doi: 10.1289/ehp.11193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.11193</ArticleId><ArticleId IdType="pmc">PMC2453164</ArticleId><ArticleId IdType="pubmed">18629318</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito A.G., Martinez-Palma L., Vargas M.R., Pehar M., Ma&#xf1;ay N., Beckman J.S., Barbeito L., Cassina P. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS. Neurobiol. Dis. 2010;37:574&#x2013;580. doi: 10.1016/j.nbd.2009.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.11.007</ArticleId><ArticleId IdType="pmc">PMC2824063</ArticleId><ArticleId IdType="pubmed">19914377</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson F.O., Atchison W.D. The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology. 2009;30:761&#x2013;765. doi: 10.1016/j.neuro.2009.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2009.07.010</ArticleId><ArticleId IdType="pmc">PMC2761528</ArticleId><ArticleId IdType="pubmed">19632272</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E.A., Dhawan U., Boudeau S., Lei S., Carlomagno Y., Knobel M., Al Mohanna L.F.A., Boomhower S.R., Newland M.C., Sherr D.H., et al. Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology. Toxicol. Sci. 2019;167:105&#x2013;115. doi: 10.1093/toxsci/kfy267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfy267</ArticleId><ArticleId IdType="pmc">PMC6317426</ArticleId><ArticleId IdType="pubmed">30371865</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajowiak A., Sty&#x15b; A., Starzy&#x144;ski R.R., Staro&#x144; R., Lipi&#x144;ski P. Misregulation of iron homeostasis in amyotrophic lateral sclerosis. Postepy. Hig. Med. Dosw. 2016;70:709&#x2013;721. doi: 10.5604/17322693.1208036.</Citation><ArticleIdList><ArticleId IdType="doi">10.5604/17322693.1208036</ArticleId><ArticleId IdType="pubmed">27356602</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti F., Fiore M., Chisari C.G., D&#x2019;Amico E., Lo Fermo S., Toscano S., Copat C., Ferrante M., Zappia M. CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: Comparison between bulbar and spinal onset. Environ. Res. 2020;188:109820. doi: 10.1016/j.envres.2020.109820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2020.109820</ArticleId><ArticleId IdType="pubmed">32615355</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesauro M., Bruschi M., Filippini T., D&#x2019;Alfonso S., Mazzini L., Corrado L., Consonni M., Vinceti M., Fusi P., Urani C. Metal(loid)s role in the pathogenesis of amyotrophic lateral sclerosis: Environmental, epidemiological, and genetic data. Environ. Res. 2021;192:110292. doi: 10.1016/j.envres.2020.110292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2020.110292</ArticleId><ArticleId IdType="pubmed">33027627</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil-Bea F.J., Aldanondo G., Lasa-Fern&#xe1;ndez H., L&#xf3;pez de Munain A., Vallejo-Illarramendi A. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis. Expert. Rev. Mol. Med. 2017;19:e7. doi: 10.1017/erm.2017.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/erm.2017.9</ArticleId><ArticleId IdType="pubmed">28597807</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitts M.W., Byrns C.N., Ogawa-Wong A.N., Kremer P., Berry M.J. Selenoproteins in nervous system development and function. Biol. Trace. Elem. Res. 2014;161:231&#x2013;245. doi: 10.1007/s12011-014-0060-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-014-0060-2</ArticleId><ArticleId IdType="pmc">PMC4222985</ArticleId><ArticleId IdType="pubmed">24974905</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbrenner H., Sies H. Selenium homeostasis and antioxidant selenoproteins in brain: Implications for disorders in the central nervous system. Arch. Biochem. Biophys. 2013;536:152&#x2013;157. doi: 10.1016/j.abb.2013.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2013.02.021</ArticleId><ArticleId IdType="pubmed">23500141</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez A.O., Mueller C.L., Morgan K.L., Szewczyk N.J., Teece L., Miranda-Vizuete A., Estevez M. Selenium induces cholinergic motor neuron degeneration in Caenorhabditis elegans. Neurotoxicology. 2012;33:1021&#x2013;1032. doi: 10.1016/j.neuro.2012.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2012.04.019</ArticleId><ArticleId IdType="pmc">PMC3445719</ArticleId><ArticleId IdType="pubmed">22560997</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campenhout K., Infante H.G., Adams F., Blust R. Induction and binding of Cd, Cu, and Zn to metallothionein in carp (Cyprinus carpio) using HPLC-ICP-TOFMS. Toxicol. Sci. 2004;80:276&#x2013;287. doi: 10.1093/toxsci/kfh149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfh149</ArticleId><ArticleId IdType="pubmed">15103052</ArticleId></ArticleIdList></Reference><Reference><Citation>Oggiano R., Pisano A., Sabalic A., Farace C., Fenu G., Lintas S., Forte G., Bocca B., Madeddu R. An overview on amyotrophic lateral sclerosis and cadmium. Neurol. Sci. 2021;42:531&#x2013;537. doi: 10.1007/s10072-020-04957-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04957-7</ArticleId><ArticleId IdType="pmc">PMC7843544</ArticleId><ArticleId IdType="pubmed">33280067</ArticleId></ArticleIdList></Reference><Reference><Citation>Maya S., Prakash T., Madhu K.D., Goli D. Multifaceted effects of aluminium in neurodegenerative diseases: A review. Biomed. Pharmacother. 2016;83:746&#x2013;754. doi: 10.1016/j.biopha.2016.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2016.07.035</ArticleId><ArticleId IdType="pubmed">27479193</ArticleId></ArticleIdList></Reference><Reference><Citation>Kihira T., Mukoyama M., Ando K., Yase Y., Yasui M. Determination of manganese concentrations in the spinal cords from amyotrophic lateral sclerosis patients by inductively coupled plasma emission spectroscopy. J. Neurol. Sci. 1990;98:251&#x2013;258. doi: 10.1016/0022-510X(90)90266-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(90)90266-P</ArticleId><ArticleId IdType="pubmed">2243233</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos E., W&#xe4;rml&#xe4;nder S.K.T.S., Meyer J., Sholts S.B., Jarvet J., Gr&#xe4;slund A., Roos P.M. Amyotrophic Lateral Sclerosis After Exposure to Manganese from Traditional Medicine Procedures in Kenya. Biol. Trace. Elem. Res. 2021;199:3618&#x2013;3624. doi: 10.1007/s12011-020-02501-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-020-02501-4</ArticleId><ArticleId IdType="pmc">PMC8360856</ArticleId><ArticleId IdType="pubmed">33230634</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Filippini T., Violi F., Rothman K.J., Costanzini S., Malagoli C., Wise L.A., Odone A., Signorelli C., Iacuzio L., et al. Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis. Environ. Health. 2017;16:91. doi: 10.1186/s12940-017-0297-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12940-017-0297-2</ArticleId><ArticleId IdType="pmc">PMC5576246</ArticleId><ArticleId IdType="pubmed">28851431</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosi L., Righetti C., Adami L., Zanette G. October 1942: A strange epidemic paralysis in Saval, Verona, Italy. Revision and diagnosis 50 years later of tri-ortho-cresyl phosphate poisoning. J. Neurol. Neurosurg. Psychiatry. 1994;57:810&#x2013;813. doi: 10.1136/jnnp.57.7.810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.57.7.810</ArticleId><ArticleId IdType="pmc">PMC1073020</ArticleId><ArticleId IdType="pubmed">8021666</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns C.J., Beard K.K., Cartmill J.B. Mortality in chemical workers potentially exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) 1945&#x2013;94: An update. Occup. Environ. Med. 2001;58:24&#x2013;30. doi: 10.1136/oem.58.1.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oem.58.1.24</ArticleId><ArticleId IdType="pmc">PMC1740039</ArticleId><ArticleId IdType="pubmed">11119631</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M., Violi F., Tzatzarakis M., Mandrioli J., Malagoli C., Hatch E.E., Fini N., Fasano A., Rakitskii V.N., Kalantzi O.I., et al. Pesticides, polychlorinated biphenyls and polycyclic aromatic hydrocarbons in cerebrospinal fluid of amyotrophic lateral sclerosis patients: A case-control study. Environ. Res. 2017;155:261&#x2013;267. doi: 10.1016/j.envres.2017.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2017.02.025</ArticleId><ArticleId IdType="pubmed">28242563</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafalou S., Abdollahi M. The link of organophosphorus pesticides with neurodegenerative and neurodevelopmental diseases based on evidence and mechanisms. Toxicology. 2018;409:44&#x2013;52. doi: 10.1016/j.tox.2018.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2018.07.014</ArticleId><ArticleId IdType="pubmed">30053494</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Pino J., Moyano P., Anadon M.J., Garc&#xed;a J.M., D&#xed;az M.J., Garc&#xed;a J., Frejo M.T. Acute and long-term exposure to chlorpyrifos induces cell death of basal forebrain cholinergic neurons through AChE variants alteration. Toxicology. 2015;336:1&#x2013;9. doi: 10.1016/j.tox.2015.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2015.07.004</ArticleId><ArticleId IdType="pubmed">26210949</ArticleId></ArticleIdList></Reference><Reference><Citation>Karami-Mohajeri S., Ahmadipour A., Rahimi H.R., Abdollahi M. Adverse effects of organophosphorus pesticides on the liver: A brief summary of four decades of research. Arh. Hig. Rada. Toksikol. 2017;68:261&#x2013;275. doi: 10.1515/aiht-2017-68-2989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/aiht-2017-68-2989</ArticleId><ArticleId IdType="pubmed">29337682</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal M.K. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Med. Res. Rev. 2019;39:733&#x2013;748. doi: 10.1002/med.21528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.G., Mitchell J.D., Lyon M., Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) Cochrane Database Syst. Rev. 2007;1:CD001447.</Citation><ArticleIdList><ArticleId IdType="pubmed">17253460</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T., Al Khleifat A., Meurgey J.H., Jones A., Leigh P.N., Bensimon G., Al-Chalabi A. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: A retrospective analysis of data from a dose-ranging study. Lancet Neurol. 2018;17:416&#x2013;422. doi: 10.1016/S1474-4422(18)30054-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30054-1</ArticleId><ArticleId IdType="pmc">PMC5899963</ArticleId><ArticleId IdType="pubmed">29525492</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Itoyama Y., Sobue G., Tsuji S., Aoki M., Doyu M., Hamada C., Kondo K., Yoneoka T., Akimoto M., et al. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:610&#x2013;617. doi: 10.3109/21678421.2014.959024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.959024</ArticleId><ArticleId IdType="pmc">PMC4266079</ArticleId><ArticleId IdType="pubmed">25286015</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Group on Behalf of the Edaravone (MCI-186) ALS 17 Study Group Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18((Suppl. 1)):20&#x2013;31. doi: 10.1080/21678421.2017.1362000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1362000</ArticleId><ArticleId IdType="pubmed">28872918</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Group. Edaravone (MCI-186) ALS 19 Study Group Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;512. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi F., Takei K., Tsuda K., Palumbo J. Post-hoc analysis of MCI186&#x2013;17, the extension study to MCI186&#x2013;16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. Frontotemporal Degener. 2017;18((Suppl. 1)):32&#x2013;39. doi: 10.1080/21678421.2017.1361442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1361442</ArticleId><ArticleId IdType="pubmed">28872914</ArticleId></ArticleIdList></Reference><Reference><Citation>Jami M.S., Salehi-Najafabadi Z., Ahmadinejad F., Hoedt E., Chaleshtori M.H., Ghatrehsamani M., Neubert T.A., Larsen J.P., M&#xf8;ller S.G. Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress. Neurochem. Int. 2015;90:134&#x2013;141. doi: 10.1016/j.neuint.2015.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2015.07.024</ArticleId><ArticleId IdType="pmc">PMC4675627</ArticleId><ArticleId IdType="pubmed">26232623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadinejad F., Geir M&#xf8;ller S., Hashemzadeh-Chaleshtori M., Bidkhori G., Jami M.-S. Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress. Antioxidants. 2017;6:51. doi: 10.3390/antiox6030051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox6030051</ArticleId><ArticleId IdType="pmc">PMC5618079</ArticleId><ArticleId IdType="pubmed">28698499</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A., Galano A. OH radical scavenging activity of Edaravone: Mechanism and kinetics. J. Phys. Chem. B. 2011;115:1306&#x2013;1314. doi: 10.1021/jp110400t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jp110400t</ArticleId><ArticleId IdType="pubmed">21190324</ArticleId></ArticleIdList></Reference><Reference><Citation>Matic I., Strobbe D., Frison M., Campanella M. Controlled and Impaired Mitochondrial Quality in Neurons: Molecular Physiology and Prospective Pharmacology. Pharmacol. Res. 2015;99:410&#x2013;424. doi: 10.1016/j.phrs.2015.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2015.03.021</ArticleId><ArticleId IdType="pubmed">25917207</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel E., Cassina A., Mart&#xed;nez-Palma L., Souza J.M., Bolatto C., Rodr&#xed;guez-Bottero S., Logan A., Smith R.A., Murphy M.P., Barbeito L., et al. Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2014;70:204&#x2013;213. doi: 10.1016/j.freeradbiomed.2014.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.02.019</ArticleId><ArticleId IdType="pubmed">24582549</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauchov&#xe1; H. Coenzyme Q10 effects in neurological diseases. Physiol. Res. 2021;70((Suppl. 4)):S683&#x2013;S714. doi: 10.33549/physiolres.934712.</Citation><ArticleIdList><ArticleId IdType="doi">10.33549/physiolres.934712</ArticleId><ArticleId IdType="pmc">PMC9054193</ArticleId><ArticleId IdType="pubmed">35199552</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarozzi A., Angeloni C., Malaguti M., Morroni F., Hrelia S., Hrelia P. Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid. Med. Cell Longev. 2013;2013:415078. doi: 10.1155/2013/415078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/415078</ArticleId><ArticleId IdType="pmc">PMC3745957</ArticleId><ArticleId IdType="pubmed">23983898</ArticleId></ArticleIdList></Reference><Reference><Citation>Sant&#xed;n-M&#xe1;rquez R., Alarc&#xf3;n-Aguilar A., L&#xf3;pez-Diazguerrero N.E., Chondrogianni N., K&#xf6;nigsberg M. Sulforaphane&#x2014;Role in aging and neurodegeneration. Geroscience. 2019;41:655&#x2013;670. doi: 10.1007/s11357-019-00061-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-019-00061-7</ArticleId><ArticleId IdType="pmc">PMC6885086</ArticleId><ArticleId IdType="pubmed">30941620</ArticleId></ArticleIdList></Reference><Reference><Citation>East D.A., Fagiani F., Crosby J., Georgakopoulos N.D., Bertrand H., Schaap M., Fowkes A., Wells G., Campanella M. PMI: A &#x394;&#x3a8;m independent pharmacological regulator of mitophagy. Chem. Biol. 2014;21:1585&#x2013;1596. doi: 10.1016/j.chembiol.2014.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2014.09.019</ArticleId><ArticleId IdType="pmc">PMC4245710</ArticleId><ArticleId IdType="pubmed">25455860</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z., Lim J., Wang Q., Purtell K., Wu S., Palomo G.M., Tan H., Manfredi G., Zhao Y., Peng J., et al. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway. Autophagy. 2020;16:917&#x2013;931. doi: 10.1080/15548627.2019.1644076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1644076</ArticleId><ArticleId IdType="pmc">PMC7144840</ArticleId><ArticleId IdType="pubmed">31362587</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J.R., Trias E., Beilby P.R., Lopez N.I., Labut E.M., Bradford C.S., Roberts B.R., McAllum E.J., Crouch P.J., Rhoads T.W., et al. Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD. Neurobiol. Dis. 2016;89:1&#x2013;9. doi: 10.1016/j.nbd.2016.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.01.020</ArticleId><ArticleId IdType="pmc">PMC4785045</ArticleId><ArticleId IdType="pubmed">26826269</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum J.S., Brown M.L., Farrawell N.E., McAlary L., Ly D., Chisholm C.G., Snow J., Vine K.L., Karl T., Kreilaus F., et al. CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1G93A mice with a C57BL/6 background. Sci. Rep. 2021;11:19392. doi: 10.1038/s41598-021-98317-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98317-w</ArticleId><ArticleId IdType="pmc">PMC8481268</ArticleId><ArticleId IdType="pubmed">34588483</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>